Statement from Assistant Secretary Lurie on FDA approval of new influenza vaccine manufactured with novel technology

FDA approved one of the most significant improvements in flu vaccine technology in the past 50 years. The advancement is the result of a public-private partnership between BARDA & Protein Sciences Corp.

From the ASPR Blog
Using Citizen Generated Data

How Studies of Bellybuttons, Roadkill & Genomics Offer an Opportunity to Improve Public Health Emergency Preparedness, Response & Recovery

The use of citizen scientists can increase the scope and feasibility of a project while simultaneously educating the community on the subject matter.

AAssistant Secretary Nicole Lurie statement on FDA approval of first anthrax antitoxin developed under Project Bioshield

With the U.S. Food and Drug Administration approval of the first drug for treatment of anthrax, our nation took a monumental step forward today in preparing for the health impacts of bioterrorism.

BARDA sponsors development of spray dried blood plasma device

BARDA contract supports development of new product to improve disaster medical care

A device to turn liquid blood plasma into sterile powder so it can be shipped and stored more effectively and rehydrated is to be developed under an $8.9 million, 18-month contract between the BARDA and Velico Medical, Inc. of Beverly, Mass.

ASPR Twitter Challenge Sparks Innovation in Tracking Local Health Trends

Local public health officials can use a free new Web-based application, MappyHealth, to track health concerns in real time in their communities using Twitter, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) announced today.